In our cohort, we noted an increased expression of the enzyme carboxypeptidase U (CPB2), which may account for the presence of dense clots seen in LC patients as the enzyme is a potent inhibitor of fibrinolysis [26]. This evidence concerns the gene CPB2 and laryngotracheoesophageal cleft.